Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease

Overview of attention for article published in BMC Neurology, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 1 news story.

. Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.